Atsushi Akahane - Concepedia

Author

Atsushi Akahane

Mochida Pharmaceutical (Japan)

Also Known As

A Akahane, A. AKAHANE, A. Akahane, Atsushi AKAHANE, Atsushi Akahane

Publications

687

Citations

H-Index

Concepts

All Affiliations

Mochida Pharmaceutical (Japan)Fujisawa City Hospital Colorado State University Tohoku University University of Edinburgh

About

Atsushi Akahane is an author at Mochida Pharmaceutical (Japan) specializing in pharmacology, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	7	7	181
2	Medicine	6	6	143
3	Natural Sciences	5	5	118
4	Engineering	3	3	73
5	Biomedical Engineering	1	1	26

Atsushi Akahane

Publications

669

Citations

H-Index

Page 1

	Year	Citations
Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-<i>a</i>]pyridin-3-yl)-1(6<i>H</i>)-pyridazinebutanoic Acid (FK 838): A Novel Non-Xanthine Adenosine A<sub>1</sub>Receptor Antagonist with Potent Diuretic Activity Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga, Journal of Medicinal Chemistry	1999	102
Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors Takuya Maemoto, Miho Tada, Takuma Mihara, Journal of Pharmacological Sciences	2004	78
Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition Takuma Mihara, Kayoko Mihara, Junko Yarimizu, Journal of Pharmacology and Experimental Therapeutics	2007	75
Pharmacological Characterization of a Simple Behavioral Response Mediated Selectively by Central Adenosine A1 Receptors, Using In Vivo and In Vitro Techniques Hugh Marston, Keith Finlayson, Takuya Maemoto, Journal of Pharmacology and Experimental Therapeutics	1998	62
Species differences in brain adenosine A<sub>1</sub> receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists Takuya Maemoto, Keith Finlayson, Henry J. Olverman, British Journal of Pharmacology	1997	58
Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-α]pyridine adenosine A1 receptor antagonist Satoru Kuroda, Atsushi Akahane, Hiromichi Itani, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryG Protein-coupled ReceptorMedicineMechanism Of Action	1999	44
Chiral formamidines. Asymmetric synthesis of 1,1-disubstituted tetrahydroisoquinolines. A. I. MEYERS, Michael A. Gonzalez, V. STRUZKA, Tetrahedron Letters Chiral FormamidinesOrganic ChemistryPharmacologyAsymmetric CatalysisEnantioselective Synthesis	1991	40
Syntheses of arborescin, 1,10-epiarborescin, and (11S)-guaia-3,10(14)-dieno-13,6.alpha.-lactone, the key intermediate in Greene and Crabbe's estafiatin synthesis, and the stereochemical assignment of arborescin Masayoshi Ando, Atsushi Akahane, Hiroaki Yamaoka, The Journal of Organic Chemistry Diversity Oriented SynthesisBiosynthesisBioorganic ChemistryKey IntermediateBiochemistry	1982	40
Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonist Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryG Protein-coupled ReceptorMedicineNatural Sciences	1996	28
Design, Synthesis and Biological Evaluation of a Novel Series of Potent, Orally Active Adenosine A<SUB>1</SUB> Receptor Antagonists with High Blood-Brain Barrier Permeability Satoru Kuroda, Fujiko Takamura, Yoshiyuki Tenda, Chemical and Pharmaceutical Bulletin Molecular PharmacologyMedicinal ChemistryNovel SeriesBiochemistryFunctional Selectivity	2001	26

Page 1